ARIBIO is a clinical-stage integrated biotech company focused on developing novel therapeutics for neurodegenerative and infectious diseases using the ARIDD™ (Advanced, Rapid and Integrated Drug Development) platform. ARIBIO dreams of a world without suffering from diseases. Even as we enjoy happiness in this moment, there are still those who are suffering from illnesses. We want to give them back their lost smiles and healthy lives. To achieve that dream, ARIBIO relentlessly strives to develop novel therapeutics.
AR1001: A Novel Oral Therapeutic Approach Addressing Unmet Needs
Alzheimer’s disease (AD) imposes substantial cognitive, functional, and societal burdens, with current emphasis on early intervention along the disease continuum.
